Evaluation of prognostic factors and establishment of a prognostic scoring system for canine primary immune-mediated hemolytic anemia

Journal of Veterinary Medical Science

Volumn 72, Issue 4, 2010, Pages 465-470

  Ishihara, Masahiro ^a   Fujino, Yasuhito ^a   Setoguchi, Asuka ^b   Takahashi, Masashi ^a   Nakashima, Ko ^a   Ohno, Koichi ^a   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Canine; Mortality; Outcome; Primary imha; Prognosis

Indexed keywords

BILIRUBIN; PLASMA PROTEIN;

ANIMAL; ANIMAL DISEASE; BLOOD; DOG; FEMALE; HEMAGGLUTINATION; HEMOLYTIC ANEMIA; IMMUNOLOGY; MALE; METABOLISM; MORTALITY; PROGNOSIS; REVIEW; SEASON; SPECIES DIFFERENCE; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; VACCINATION;

ANEMIA, HEMOLYTIC; ANIMALS; BILIRUBIN; BLOOD PROTEINS; BLOOD UREA NITROGEN; DOGS; FEMALE; HEMAGGLUTINATION; MALE; PLATELET COUNT; PROGNOSIS; SEASONS; SPECIES SPECIFICITY; SURVIVAL RATE; THROMBOCYTOPENIA; VACCINATION;

CANIS FAMILIARIS;

EID: 77951893926     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.09-0283     Document Type: Review

References (26)

1. Bexfield, N. H., Villiers, E. J. and Herrtage, M. E. 2005. Immune-mediated haemolytic anaemia and thrombocytopenia associated with Anaplasma phagocytophilum in a dog. J. Small Anim. Pract. 46: 543-548.
2. Burgess, K., Moore, A., Rand, W. and Cotter, S. M. 2000. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide. J. Vet. Intern. Med. 14: 456-462.
3. Carr, A. P., Panciera, D. L. and Kidd, L. 2002. Prognostic fac- tors for mortality and thromboembolism in canine immune- mediated hemolytic anemia: a retrospective study of 72 dogs. J. Vet. Intern. Med. 16: 504-509.
4. Duval, D. and Giger, U. 1996. Vaccine-associated immune- mediated hemolytic anemia in the dog. J. Vet. Intern. Med. 10: 290-295.
5. Feldman, B. F., Madewell, B. R. and O'Neill, S. 1981. Dissem- inated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs. J. Am. Vet. Med. Assoc. 179: 151-154.
6. Grundy, S. A. and Barton, C. 2001. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999). J. Am. Vet. Med. Assoc. 218: 543-546.
7. Jackson, M. L. and Kruth, S. A. 1985. Immune-mediated hemolytic anemia and thrombocytopenia in the dog: a retrospective study of 55 cases diagnosed from 1979 through 1983 at the Western College of Veterinary Medicine. Can. Vet. J. 26: 245-250.
8. Johnson, L. R., Lappin, M. R. and Baker, D. C. 1999. Pulmonary thromboembolism in 29 dogs: 1985-1995. J. Vet. Intern. Med. 13: 338-345.
9. Keller, E. T. 1992. Immune-mediated disease as a risk factor for canine lymphoma. Cancer 70: 2334-2337.
10. Kellerman, D.L. and Bruyette, D. S. 1997. Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs. J. Vet. Intern. Med. 11: 327-332.
11. Kelton, J. G., Carter, C.J., Santos, A. and Hirsh, J. 1982. Sex related differences in platelet function: the effect of aspirin. Blood 59: 625-627.
12. Klag, A. R., Giger, U. and Shofer, F. S. 1993. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990). J. Am. Vet. Med. Assoc. 202: 783-788.
13. Klein, M. K., Dow, S. W. and Rosychuk, R. A. 1989. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987). J. Am. Vet. Med. Assoc. 195: 246-250.
14. Lewis, R. M., Schwartz, R. and Henry, W. B. Jr. 1965. Canine systemic lupus erythematosus. Blood 25: 143-160.
15. Lobetti, R. G. and Schoeman, T. 2001. Immune-mediated haemolytic anaemia: possible association with Ancylostoma caninum infection in three dogs. J. S. Afr. Vet. Assoc. 72: 52-54
16. Mason, N., Duval, D., Shofer, F. S. and Giger, U. 2003. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial. J. Vet. Intern. Med. 17: 206-212.
17. Mathe, A., Voros, K., Papp, L. and Reiczigel, J. 2006. Clinical manifestations of canine babesiosis in Hungary (63 cases). Acta Vet. Hung. 54: 367-385.
18. McCullough, S. 2003. Immune-mediated hemolytic anemia: understanding the nemesis. Vet. Clin. North Am. Small Anim. Pract. 33: 1295-1315.
19. McManus, P. M. and Craig, L. E. 2001. Correlation between leukocytosis and necropsy findings in dogs with immunemediated hemolytic anemia: 34 cases (1994-1999). J. Am. Vet. Med. Assoc. 218: 1308-1313.
20. Miller, S. A., Hohenhaus, A. E. and Hale, A. S. 2004. Casecontrol study of blood type, breed, sex, and bacteremia in dogs with immune-mediated hemolytic anemia. J. Am. Vet. Med. Assoc. 224: 232-235.
21. Ohno, H., Tojo, H., Kakihata, K., Nomura, M. and Takayama, S. 1993. Heinz body hemolytic anemia induced by DQ-2511, a new anti-ulcer drug, in dogs. Fundam. Appl. Toxicol. 20: 141-146
22. Papazoglou, L. G., Monnet, E. and Seim, H. B. 3rd. 2002. Survival and prognostic indicators for dogs with intrahepatic portosystemic shunts: 32 cases (1990-2000). Vet. Surg. 31: 561-570
23. Reimer, M. E., Troy, G. C. and Warnick, L. D. 1999. Immunemediated hemolytic anemia: 70 cases (1988-1996). J. Am. Anim. Hosp. Assoc. 35: 384-391.
24. Scott-Moncrieff, J. C., Reagan, W. J., Snyder, P. W. and Glickman, L. T. 1997. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia. J. Am. Vet. Med. Assoc. 210: 1623-1627.
25. Scott-Moncrieff, J. C., Treadwell, N. G., McCullough, S. M. and Brooks, M. B. 2001. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J. Am. Anim. Hosp. Assoc. 37: 220-227.
26. Weinkle, T. K., Center, S. A., Randolph, J. F., Warner, K. L., Barr, S. C. and Erb, H. N. 2005. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J. Am. Vet. Med. Assoc. 226: 1869-1880.